Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Busse

Showing results (551-560 of 5,063) with videos related to

Pageof 507
Sort By:
Contributions to Microbiology|August 9, 2007
Human rhinovirus models in asthmaAnne Marie Singh, William W Busse
Thorax|August 29, 2006
Asthma exacerbations. 2: aetiologyA M Singh, W W Busse
American Journal of Respiratory and Critical Care Medicine|May 1, 1998
AsthmaJ A Nadel, W W Busse
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 11, 2020
How to compare the efficacy of biologic agents in asthmaRavi K Viswanathan, William W Busse
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 1, 1997
[Lacrimal duct surgery in childhood. Retrospective study at the Munster University Ophthalmology Clinic]W Förster, A Peter, H Busse
Journal of Computer-Aided Molecular Design|October 1, 1992
'ValleyScan': a new two-bond drive technique for the calculation of potential energy surfaces with less computational effortG Bringmann, S Güssregen, H Busse
International Journal of Technology Assessment in Health Care|December 30, 2015
CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICESDimitra Panteli, Julia Kreis, Reinhard Busse
The Journal of Allergy and Clinical Immunology|February 12, 2022
Weaving innate lymphoid cells (ILCs) into the fabric of asthma exacerbationsWilliam W Busse, James E Gern
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2022
Perspectives in Respiratory Infections and the LungAnne M Fitzpatrick, William W Busse
Therapeutics and Clinical Risk Management|August 14, 2018
Angiotensin II: a new therapeutic option for vasodilatory shockRachel L Bussard, Laurence W Busse
Pageof 507

Showing results (551-560 of 5,063) with videos related to

Sort By:
Pageof 507
Contributions to Microbiology|August 9, 2007
Human rhinovirus models in asthmaAnne Marie Singh, William W Busse
Thorax|August 29, 2006
Asthma exacerbations. 2: aetiologyA M Singh, W W Busse
American Journal of Respiratory and Critical Care Medicine|May 1, 1998
AsthmaJ A Nadel, W W Busse
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 11, 2020
How to compare the efficacy of biologic agents in asthmaRavi K Viswanathan, William W Busse
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 1, 1997
[Lacrimal duct surgery in childhood. Retrospective study at the Munster University Ophthalmology Clinic]W Förster, A Peter, H Busse
Journal of Computer-Aided Molecular Design|October 1, 1992
'ValleyScan': a new two-bond drive technique for the calculation of potential energy surfaces with less computational effortG Bringmann, S Güssregen, H Busse
International Journal of Technology Assessment in Health Care|December 30, 2015
CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICESDimitra Panteli, Julia Kreis, Reinhard Busse
The Journal of Allergy and Clinical Immunology|February 12, 2022
Weaving innate lymphoid cells (ILCs) into the fabric of asthma exacerbationsWilliam W Busse, James E Gern
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2022
Perspectives in Respiratory Infections and the LungAnne M Fitzpatrick, William W Busse
Therapeutics and Clinical Risk Management|August 14, 2018
Angiotensin II: a new therapeutic option for vasodilatory shockRachel L Bussard, Laurence W Busse
Pageof 507